Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Total Revenue | - | 572.33 | 600.47 | 720.87 | 821.16 |
| Operating Revenue | - | 563.57 | 590.83 | 710.29 | 813.41 |
| Cost Of Revenue | 101.48 | 110.16 | 122.29 | 152.11 | - |
| Gross Profit | 371.93 | 462.17 | 478.18 | 568.76 | - |
| Operating Expense | - | 649.84 | 727.49 | 828.68 | 928.11 |
| Research And Development | - | 115.04 | 119.20 | 134.63 | 155.42 |
| Selling General And Administration | - | 254.57 | 297.58 | 325.10 | 376.56 |
| Total Expenses | - | 649.84 | 727.49 | 828.68 | 928.11 |
| Operating Income | - | -77.51 | -127.02 | -107.82 | -106.95 |
| Total Operating Income As Reported | - | -22.21 | 103.61 | 149.03 | 124.67 |
| EBITDA | - | 32.61 | -99.21 | -60.52 | 190.29 |
| Normalized EBITDA | - | -1.36 | -116.57 | -48.54 | 190.29 |
| EBIT | - | 11.75 | -127.02 | -107.82 | 124.67 |
| Interest Income | - | 55.29 | 242.20 | 259.26 | 231.61 |
| Interest Expense | - | 10.13 | - | - | 9.08 |
| Net Interest Income | - | 45.16 | 242.20 | 259.26 | 222.54 |
| Other Income Expense | 11.82 | 33.96 | 17.36 | -11.98 | - |
| Interest Income Non Operating | - | 55.29 | 242.20 | 259.26 | 231.61 |
| Interest Expense Non Operating | - | 10.13 | - | - | 9.08 |
| Net Non Operating Interest Income Expense | - | 45.16 | 242.20 | 259.26 | 222.54 |
| Pretax Income | - | 1.62 | 132.54 | 139.47 | 115.59 |
| Tax Provision | - | 13.59 | 39.20 | 18.31 | 42.40 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | 7.13 | 5.13 | -1.57 | 0 |
| Net Income Continuous Operations | - | -11.97 | 93.33 | 121.16 | 73.19 |
| Net Income From Continuing And Discontinued Operation | - | -11.97 | 93.33 | 121.16 | 73.19 |
| Net Income From Continuing Operation Net Minority Interest | - | -11.97 | 93.33 | 121.16 | 73.19 |
| Net Income | - | -11.97 | 93.33 | 121.16 | 73.19 |
| Net Income Common Stockholders | - | -11.97 | 93.33 | 121.16 | 73.19 |
| Net Income Including Noncontrolling Interests | - | -11.97 | 93.33 | 121.16 | 73.19 |
| Normalized Income | - | -38.80 | 81.11 | 131.57 | 73.19 |
| Diluted NI Availto Com Stockholders | - | -11.97 | 93.33 | 121.16 | 73.19 |
| Basic Average Shares | 202.88 | 348.04 | 361.68 | 358.35 | - |
| Diluted Average Shares | 202.88 | 348.04 | 392.67 | 386.24 | - |
| Reconciled Depreciation | - | 20.24 | 27.49 | 45.45 | 63.73 |
| Reconciled Cost Of Revenue | 101.48 | 110.78 | 122.29 | 153.96 | - |
| Total Unusual Items | 11.82 | 33.96 | 17.36 | -11.98 | - |
| Total Unusual Items Excluding Goodwill | 11.82 | 33.96 | 17.36 | -11.98 | - |
| Preferred Stock Dividends | 33.63 | - | - | - | - |
| Earnings From Equity Interest Net Of Tax | -0.04 | 0 | 0 | 0 | - |
| Gain On Sale Of Security | 11.82 | 33.96 | 17.36 | -11.98 | - |
| Depreciation Amortization Depletion Income Statement | - | 20.86 | 27.81 | 47.30 | 65.62 |
| Depreciation And Amortization In Income Statement | - | 20.86 | 27.81 | 47.30 | 65.62 |
| General And Administrative Expense | - | 90.01 | 100.93 | 113.26 | 141.40 |
| Other Gand A | - | 90.01 | 100.93 | 113.26 | 141.40 |
| Total Other Finance Cost | 6.85 | 10.13 | -11.57 | - | - |
| Other Operating Expenses | - | 259.36 | 282.90 | 321.66 | 330.50 |
| Selling And Marketing Expense | - | 164.56 | 196.65 | 211.84 | 235.15 |